Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Operating Expenses | 3,668 | 6,750 | 4,562 | 4,842 | 18,309 |
Operating Income | -3,668 | -6,750 | -4,562 | -4,842 | -18,309 |
Interest Expense | 92 | 116 | 35 | 33 | 39 |
Other Income | 408 | 3,725 | -435 | -224 | 14,041 |
Pre-tax Income | -3,352 | -3,141 | -5,032 | -5,099 | -4,307 |
Income Tax | N/A | -285 | -5 | -4 | -1,227 |
Net Income Continuous | -3,352 | -2,856 | -5,027 | -5,095 | -3,080 |
Net Income | $-3,352 | $-2,838 | $-5,037 | $-5,103 | $-3,080 |
EPS Basic Total Ops | -190,872.70 | -792,570.60 | -561,135.10 | -32,372.37 | -471,831.80 |
EPS Basic Continuous Ops | -190,645.20 | -657,254.00 | -422,091.30 | -25,453.20 | -312,460.10 |
EPS Diluted Total Ops | -190,872.70 | -792,570.60 | -561,135.10 | -32,372.37 | -471,831.80 |
EPS Diluted Continuous Ops | -190,645.20 | -657,254.00 | -422,091.30 | -25,453.20 | -312,460.10 |
EPS Diluted Before Non-Recurring Items | -106,426.40 | N/A | -571,200.62 | N/A | N/A |
EBITDA(a) | $-3,658 | $-3,184 | $-4,551 | $-4,818 | $-4,279 |